Saturable CD14-Dependent Binding of Fluorescein-Labeled Lipopolysaccharide to Human Monocytes

作者: A Troelstra , P Antal-Szalmas , L A de Graaf-Miltenburg , A J Weersink , J Verhoef

DOI: 10.1128/IAI.65.6.2272-2277.1997

关键词:

摘要: We used rough lipopolysaccharide (ReLPS) to construct a fluorescein-labeled LPS (FITC-LPS) with very high labeling efficiency that bound isolated human monocytes in CD14-dependent fashion and this respect behaved indistinctively from native LPS. The binding could be inhibited either by 1,000-fold excess of unlabeled or polymyxin B, bactericidal/permeability-increasing protein, cationic protein 18, soluble CD14. Although FITC-LPS preparation no longer possessed the ability prime neutrophils for production reactive oxygen species stimulate produce tumor necrosis factor, activation Limulus amoebocyte lysate cascade was comparable Binding enhanced pooled serum (HPS) LPS-binding (LBP) concentrations up 100 ng/ml completely CD14 dependent. For exceeding ng/ml, still partially dependent, but not HPS LBP association shown totally saturable. In conclusion, we found an HPS- LBP-dependent dependent at ng per ml, saturation shown.

参考文章(43)
Richard J. Ulevitch, Recognition of bacterial endotoxins by receptor-dependent mechanisms. Advances in Immunology. ,vol. 53, pp. 267- 289 ,(1993) , 10.1016/S0065-2776(08)60502-7
K. P. M. Van Kessel, A. J. L. Weersink, I. Corrales, J. Verhoef, Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14. Immunology. ,vol. 80, pp. 84- 89 ,(1993)
N Haeffner-Cavaillon, M D Kazatchkine, M Caroff, C Couturier, Binding sites for endotoxins (lipopolysaccharides) on human monocytes Journal of Immunology. ,vol. 147, pp. 1899- 1904 ,(1991)
R J Ulevitch, P Gallay, P S Tobias, C Barras, M P Glauser, D Heumann, J D Baumgartner, P Zaech, Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. Journal of Immunology. ,vol. 148, pp. 3505- 3512 ,(1992)
Guo-Wei Rong, J. Silver, S. M. Goyert, V. Bazil, A. Haziot, Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. Journal of Immunology. ,vol. 152, pp. 5868- 5876 ,(1994)
J J Seilhamer, J L Snable, C G Wilde, R W Scott, J C Lane, N Ashton, K L Miller, M B Thornton, S R Leong, M McGrogan, Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation. Journal of Biological Chemistry. ,vol. 269, pp. 17411- 17416 ,(1994) , 10.1016/S0021-9258(17)32454-7
T N Kirkland, F Finley, D Leturcq, A Moriarty, J D Lee, R J Ulevitch, P S Tobias, Analysis of lipopolysaccharide binding by CD14. Journal of Biological Chemistry. ,vol. 268, pp. 24818- 24823 ,(1993) , 10.1016/S0021-9258(19)74538-4
N Haeffner-Cavaillon, J M Cavaillon, R Chaby, L Szabó, Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. Journal of Immunology. ,vol. 128, pp. 1950- 1954 ,(1982)
Guo-Wei Rong, J. Silver, S. M. Goyert, A. Haziot, Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. Journal of Immunology. ,vol. 151, pp. 1500- 1507 ,(1993)
J. A. G. Van Strijp, Jan Verhoef, R. Torensma, K. P. M. Van Kessel, A. J. L. Weersink, Binding of rough lipopolysaccharides (LPS) to human leukocytes : inhibition by anti-LPS monoclonal antibody Journal of Immunology. ,vol. 145, pp. 318- 324 ,(1990)